Your online Gateway to Jost Chemical Co. in 2011
"Quality Delivered On-Time"
8150 Lackland
St. Louis, MO 63114
Phone: +1.314.428.4300
Fax: +1.314.428.4366
www.jostchemical.com
For over 25 years Jost Chemical Co. has manufactured high purity specialty chemicals for the pharmaceutical, nutritional, food and reagent market. Jost’s St. Louis, MO site, comprised of two manufacturing buildings totaling 190,000 ft2, is FDA registered and operates under ICH Q7 bulk pharmaceutical cGMP’s. Our 250+ high purity chemical salts are manufactured to meet USP/EP/BP/JP/ACS/FCC and multi-compendia requirements and are BSE/TSE free and allergen free. By continually focusing on product quality through controlled validated processes and lot-to-lot product consistency, Jost is able to meet specific product requirements and if required can develop a DMF, ASMF and CEP. Packaging options include fiber drums, poly drums, poly pails, cartons, super sacks, etc. Custom packaging is also available. Please visit Jost’s website at www.jostchemical.com to access information on product specifications, MSDS’s and various product certifications.
Visit our Stand: Number FOD10
We look forward to meeting with you at the 2011 CPhI Exhibition in Frankfurt, Germany to discuss how Jost Chemical can assist in your drug development projects. Please contact Jeff Lenger, Director of Sales and Marketing, to arrange a meeting at CPhI. Jeff can be contacted at jeff.lenger@jostchemical.com
Coming soon!
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.